Assertio Holdings, Inc. (ASRT)Healthcare | Drug Manufacturers - Specialty & Generic | Lake Forest, United States | NasdaqCM
18.01 USD
-0.01
(-0.055%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 18.01 Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 10:17 p.m. EDT
Peak divestment from fundamentals (ongoing loss-making, negative free cash flow, declining revenue) and the appearance of shareholder class-action litigation create a toxic environment. While short-term price independence is plausible due to low beta and lack of analyst coverage, the structural damage to profitability and the legal overhang render this a 'sell/avoid' candidate with zero long-term upside potential. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.162644 |
| AutoTheta | 0.163693 |
| AutoETS | 0.163713 |
| AutoARIMA | 0.163713 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 340.33 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.030 |
| Excess Kurtosis | -1.42 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 42.844 |
| Revenue per Share | 18.54 |
| Market Cap | 116,257,448 |
| Forward P/E | 6.95 |
| Beta | 0.43 |
| Profit Margins | -25.59% |
| Website | https://www.assertiotx.com |
As of April 18, 2026, 10:17 p.m. EDT: Options activity reveals a predominantly bearish sentiment split between expirations. In June and September, there is massive open interest (OI) in out-of-the-money (OTM) puts (strikes $2-$10), particularly $19.00 and $19.00 in long-dated Puts, indicating expectations for downside? analysis. Conversely, OTM call OI is negligible (e.g., June 10.0 call has OI 19, but June 17.0 call OI is 0). The near-term April 17th data is sparse with very low volume/oi, likely due to proximity to expiry or lack of trading interest. The disparity between high put OI and near-zero call OI in mid-term suggests speculators are positioning for a significant decline or hedging existing upside exposure.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.0350282 |
| Address1 | 100 South Saunders Road |
| Address2 | Suite 300 |
| All Time High | 2,024.4 |
| All Time Low | 7.65 |
| Ask | 20.56 |
| Ask Size | 1 |
| Audit Risk | 3 |
| Average Analyst Rating | 2.5 - Buy |
| Average Daily Volume10 Day | 339,410 |
| Average Daily Volume3 Month | 124,829 |
| Average Volume | 124,829 |
| Average Volume10Days | 339,410 |
| Beta | 0.433 |
| Bid | 15.49 |
| Bid Size | 1 |
| Board Risk | 4 |
| Book Value | 14.63 |
| City | Lake Forest |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 18.01 |
| Current Ratio | 1.699 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 18.072 |
| Day Low | 18.01 |
| Debt To Equity | 42.844 |
| Display Name | Assertio |
| Earnings Call Timestamp End | 1,773,693,000 |
| Earnings Call Timestamp Start | 1,773,693,000 |
| Earnings Timestamp | 1,773,691,200 |
| Earnings Timestamp End | 1,778,529,600 |
| Earnings Timestamp Start | 1,778,529,600 |
| Ebitda | 12,782,000 |
| Ebitda Margins | 0.10767 |
| Enterprise To Ebitda | 7.27 |
| Enterprise To Revenue | 0.783 |
| Enterprise Value | 92,925,352 |
| Eps Current Year | -0.58 |
| Eps Forward | 2.59 |
| Eps Trailing Twelve Months | -4.74 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 510 744 8001 |
| Fifty Day Average | 14.4204 |
| Fifty Day Average Change | 3.5896006 |
| Fifty Day Average Change Percent | 0.24892518 |
| Fifty Two Week Change Percent | 103.50282 |
| Fifty Two Week High | 20.45 |
| Fifty Two Week High Change | -2.4400005 |
| Fifty Two Week High Change Percent | -0.11931542 |
| Fifty Two Week Low | 8.55 |
| Fifty Two Week Low Change | 9.46 |
| Fifty Two Week Low Change Percent | 1.1064327 |
| Fifty Two Week Range | 8.55 - 20.45 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 881,159,400,000 |
| Float Shares | 5,625,788 |
| Forward Eps | 2.59 |
| Forward P E | 6.953668 |
| Free Cashflow | -16,582,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 53 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.70195 |
| Gross Profits | 83,330,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01698 |
| Held Percent Institutions | 0.34794 |
| Implied Shares Outstanding | 6,455,161 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,766,707,200 |
| Last Split Factor | 1:15 |
| Long Business Summary | Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois. |
| Long Name | Assertio Holdings, Inc. |
| Market | us_market |
| Market Cap | 116,257,448 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_363049 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -30,375,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 116,257,449 |
| Number Of Analyst Opinions | 3 |
| Open | 18.04 |
| Operating Cashflow | -28,182,000 |
| Operating Margins | -1.05221 |
| Overall Risk | 2 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.89 |
| Phone | 224 419 7106 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 18.01 |
| Post Market Time | 1,776,467,155 |
| Previous Close | 18.02 |
| Price Eps Current Year | -31.051725 |
| Price Hint | 2 |
| Price To Book | 1.2310321 |
| Price To Sales Trailing12 Months | 0.9793152 |
| Profit Margins | -0.25586998 |
| Quick Ratio | 1.439 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.5 |
| Region | US |
| Regular Market Change | -0.0100002 |
| Regular Market Change Percent | -0.0554952 |
| Regular Market Day High | 18.072 |
| Regular Market Day Low | 18.01 |
| Regular Market Day Range | 18.01 - 18.072 |
| Regular Market Open | 18.04 |
| Regular Market Previous Close | 18.02 |
| Regular Market Price | 18.01 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 617,978 |
| Return On Assets | -0.03902 |
| Return On Equity | -0.28250998 |
| Revenue Growth | -0.579 |
| Revenue Per Share | 18.54 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 6,455,161 |
| Shares Percent Shares Out | 0.0468 |
| Shares Short | 301,837 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 255,059 |
| Short Name | Assertio Holdings, Inc. |
| Short Percent Of Float | 0.0475 |
| Short Ratio | 2.22 |
| Source Interval | 15 |
| State | IL |
| Symbol | ASRT |
| Target High Price | 28.0 |
| Target Low Price | 18.0 |
| Target Mean Price | 21.33333 |
| Target Median Price | 18.0 |
| Total Cash | 63,405,000 |
| Total Cash Per Share | 9.838 |
| Total Debt | 40,253,000 |
| Total Revenue | 118,713,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.74 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 12.2703 |
| Two Hundred Day Average Change | 5.7397003 |
| Two Hundred Day Average Change Percent | 0.4677718 |
| Type Disp | Equity |
| Volume | 617,978 |
| Website | https://www.assertiotx.com |
| Zip | 60,045 |